Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
44.9M
-
Shares change
-
+628K
-
Total reported value, excl. options
-
$2.85B
-
Value change
-
+$37.9M
-
Put/Call ratio
-
0.74
-
Number of buys
-
75
-
Number of sells
-
-47
-
Price
-
$63.44
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q3 2021
150 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2021.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.9M shares
of 75.6M outstanding shares and own 59.4% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.03M shares), PERCEPTIVE ADVISORS LLC (4.85M shares), Bain Capital Life Sciences Investors, LLC (4.83M shares), FMR LLC (4.02M shares), VANGUARD GROUP INC (2.86M shares), BlackRock Inc. (2.44M shares), BOXER CAPITAL, LLC (2.08M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.64M shares), STATE STREET CORP (1.33M shares), and BANK OF AMERICA CORP /DE/ (1.14M shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.